CBCC-Vibgyor Research (formerly known as Vibgyor Scientific Research) is a therapeutically focused, boutique contract research organization providing a wide spectrum of clinical research services for Phase II-IV clinical trials and Post Marketing Registry trials, to the Pharmaceutical, Biotechnology and Medical device companies.
CBCC-Vibgyor was established in the year 2000 with a vision to provide streamlined, cost effective and high-quality contract research services to help pharma, biotech and device companies to accelerate delivery of safe therapeutics. In 2012, we collaborated with CBCC USA to expand our horizon in terms of therapeutic areas as well as business activities. CBCC USA (www.cbccusa.com ) is an oncology focused, research oriented organization based in California, USA.
We strongly believe in collaborative approach. We believe in being your partners in the clinical trial process – an extension of your in house team. This proactive approach has enabled us to be focused and engage as consultative partners and participate in the clinical trial management strategies from the beginning. The partnership philosophy has helped us achieve greater start up times, superior quality in the most efficient manner with uncompromising ethical and quality standards.
Our Sponsor portfolio encompasses a variety of companies ranging from small and medium to large global enterprises. In view of the fact that the core strength and expertise of our Sponsors rest in the area of Discovery and Innovation, we aim to provide personalized service with quick turnaround time and high level of commitment and integrity. We take pride in the execution of each project and are inclined to long-term client relationships by promising support and performance all through the product development pathway.
ISO 9001:2008 certification for Quality Management in the year 2008 exhibits on our strong emphasis on customer satisfaction, management responsibility, process improvement and organizational performance measurement.
We envisage being the preferred service provider for pharmaceutical and device industries. This is driven around our self-perpetuating business model whereby the quality of our work and commitment to fulfill sponsor needs will continuously attract repeat business. As a testament to this, we continue to expand our revenues and personnel each year which is spurred entirely through repeat business and the addition of new clients by word of mouth.